Drug intelligence / Profile preview

Huamoyan Keli

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

Huamoyan Keli is a traditional Chinese patent medicine formulated as granules or capsules. It is a complex herbal preparation containing multiple active compounds, including neochlorogenic acid, protocatechualdehyde, chlorogenic acid, cryptochlorogenic acid, caffeic acid, rosmarinic acid, and salvianolic acid A. The drug is primarily indicated for the treatment of synovitis, an inflammatory condition affecting the synovial membrane of joints. Its therapeutic effects are believed to stem from the anti-inflammatory and antioxidant properties of its various herbal constituents, which work synergistically within the framework of Traditional Chinese Medicine principles to alleviate inflammation and modulate immune responses.

Brand names: 滑膜炎颗粒
Other names: Huamaoyan GranulesHuamaoyan CapsulesHMYGHMYC

Beyond the preview

Go deeper on Huamoyan Keli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huamoyan Keli.

Explore the full profile